MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04821nam a22005895i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
TR-AnTOB |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231109085833.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
211124s2022 sz | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783030812614 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1007/978-3-030-81261-4 |
| Source of number or code |
doi |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
TR-AnTOB |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
TR-AnTOB |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QZ 270 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MMN |
| Source |
bicssc |
|
|---|
| Subject category code |
MED080000 |
| Source |
bisacsh |
|
|---|
| Subject category code |
MKR |
| Source |
thema |
| 096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
|---|
| Classification number |
QZ270EBK |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
İngilizce |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Nuclear Medicine and Immunology |
| Medium |
[electronic resource] / |
| Statement of responsibility, etc. |
edited by Sara Harsini, Abass Alavi, Nima Rezaei. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1st ed. 2022. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Cham : |
| Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
| -- |
Imprint: Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. Molecular Imaging in Inflammatory and Autoimmune Disorders -- 2. Gallium Imaging of Infection and Inflammation -- 3. 111Indium-Labeled Leukocyte Imaging of Infection and Inflammation -- 4. 99mTc-HMPAO-Labeled-Leukocyte Imaging of Infection and Inflammation -- 5. FDG-PET Imaging of Infection and Inflammation -- 6. Imaging Procedures with Radiolabeled Monoclonal Antibodies -- 7. Dosimetric Principles of Targeted Radiotherapy -- 8. Radioimmunotherapy (RIT) -- 9. Peptide Receptor Radionuclide Therapy (PRRT) -- 10. Tumor Architecture and Targeted Delivery -- 11. Antibodies and Novel Constructs for Tumor Targeting -- 12. Pretargeted Radioimmunotherapy of Cancer -- 13. Radioimmunotherapy of Lymphoma -- 14. Radioimmunotherapy in Brain Tumors -- 15. Radioimmunotherapy of Pancreatic Adenocarcinoma -- 16. Radioimmunotherapy of Renal Cell Carcinoma -- 17. Radioimmunotherapy of Prostate Carcinoma -- 18. Radioimmunotherapy of Ovarian Cancer -- 19. Targeted Radiotherapy in the Treatment of Osteosarcoma -- 20. Targeted Radiotherapy of Neuroblastoma -- 21. Targeted Radiotherapy of Squamous Cell Carcinoma of the Head and Neck -- 22. Moving Forward: Expected Opportunities for the Development of New Therapeutic Agents -- 23. Translation of Radiopharmaceuticals from Bench to Bedside. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
This book explores the close connection between immunology and nuclear medicine, which has led to radioimmunoimaging and radioimmunotherapy (RIT). Molecular imaging with positron emission tomography (PET) and single-photon emission computed tomography (SPECT) is increasingly being used to diagnose, characterize, and monitor disease activity in the context of inflammatory disorders of known and unknown etiology, such as sarcoidosis, atherosclerosis, vasculitis, inflammatory bowel disease, rheumatoid arthritis, and degenerative joint disease. The first chapters discuss the various radiopharmaceutical agents and radiolabeled preparations that have been employed in inflammation imaging. Of these, FDG-PET imaging has been shown to have the great value in the detection of inflammation and has become the centerpiece of several initiatives over the last several years. This very powerful technique will play an increasingly important role in the management of patients with inflammatory conditions in the future. The book also explores the growing role of nuclear medicine and molecular imaging in the diagnosis and treatment of cancer. The rapid pace of change has been fueled by advances in our understanding of tumor biology, on the one hand, and the development of specifically targeted medical therapies, diagnostic agents, and radiotherapies, on the other. Written by leading international experts in the field, this book is an invaluable tool for nuclear medicine physicians, radiologists, oncologists, and immunologists. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Nuclear medicine. |
|
|---|
| Topical term or geographic name entry element |
Oncology. |
|
|---|
| Topical term or geographic name entry element |
Radiology. |
|
|---|
| Topical term or geographic name entry element |
Immunology. |
|
|---|
| Topical term or geographic name entry element |
Nuclear Medicine. |
|
|---|
| Topical term or geographic name entry element |
Oncology. |
|
|---|
| Topical term or geographic name entry element |
Radiology. |
|
|---|
| Topical term or geographic name entry element |
Immunology. |
| 653 #0 - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Radioimmunotherapy -- methods |
|
|---|
| Uncontrolled term |
Neoplasms -- diagnostic imaging |
|
|---|
| Uncontrolled term |
Radioimmunodetection -- methods |
|
|---|
| Uncontrolled term |
Radiopharmaceuticals -- therapeutic use |
|
|---|
| Uncontrolled term |
Positron-Emission Tomography |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Harsini, Sara. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
|
|---|
| Personal name |
Alavi, Abass. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
|
|---|
| Personal name |
Rezaei, Nima. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-030-81261-4">https://doi.org/10.1007/978-3-030-81261-4</a> |
| Materials specified |
Springer eBooks |
| Public note |
Online access link to the resource |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
National Library of Medicine |
| Koha item type |
E-Book |
